TNXA and thrombophilia: Moreover, anti-Xa levels provide no information about the effect of UFH in case of inflammation and hypercoagulability (with elevated factor VIII among other changes), which is a cause of dissociation between the two assays, with anti-Xa level in the therapeutic range but aPTT below the therapeutic range.56